Collectively, our novel findings demonstrated that the pharmacological action of CTRP9 may have important translational value in the treatment of type 2 diabetes mellitus‒accelerated atherosclerosis. The gene discussed is C1QTNF9; the disease is type 2 diabetes mellitus.